Newsletter - Alzheimer Europe December 2025 newsletter

Newsletter - Alzheimer Europe December 2025 newsletter https://alzheimereurope.newsweaver.com/Newsletter/ en-us 05 Jan 2026 09:46:04 CET 05 Jan 2026 09:46:04 CET https://alzheimereurope.newsweaver.com/Newsletter/rss.xml Newsweaver info@alzheimer-europe.org () support@newsweaver.ie (Newsweaver) 60 true Welcome https://alzheimereurope.newsweaver.com/Newsletter/j2bivp9okog?lang=en?rss=true Alzheimer Europe's December [ https://alzheimereurope.newsweaver.com/Newsletter/1105e29zioj/external ] 2025 newsletter [ https://alzheimereurope.newsweaver.com/Newsletter/1105e29zioj/external ] [ https://alzheimereurope.newsweaver.com/Newsletter/1105e29zioj/external ] brings you the latest news on developments in the dementia field, across Europe and beyond. Summaries of a few of our top stories appear below. Our monthly newsletter reaches almost 11,000 people, who have an interest in dementia, from across Europe and beyond. We are always happy to receive feedback, or suggestions regarding news items to share. [ https://alzheimereurope.newsweaver.com/Newsletter/1105e29zioj/external ] 23 Dec 2025 12:00:00 CET b1045baa17497f2c55a6350bcd9d4e4e Feature Article <img align="left" src="https://alzheimereurope.newsweaver.com/v3files/shard1/56305/19/ea8a85fca407401059a769.jpg" style="margin: 5px;" width="133" height="200" hspace="5" vspace="5" alt="Executive Director Jean Georges, June 2024">Alzheimer Europe's <a href="https://alzheimereurope.newsweaver.com/Newsletter/1105e29zioj/external" target="_blank" rel="noreferrer noopener">December 2025 newsletter</a> brings you the latest news on developments in the dementia field, across Europe and beyond. Summaries of a few of our top stories appear below. Our monthly newsletter reaches almost 11,000 people, who have an interest in dementia, from across Europe and beyond. We are always happy to receive feedback, or suggestions regarding news items to share.   <a href="https://alzheimereurope.newsweaver.com/Newsletter/1105e29zioj/external" target="_blank" rel="noreferrer noopener"><img align="middle" src="https://alzheimereurope.newsweaver.com/v3files/shard1/56305/33/9a2b2c753c2ca4ee114ecc.jpg" style="margin: 0px;" width="200" height="48" hspace="0" vspace="0" alt=""></a> 2 December: Alzheimer Europe hosts a European Parliament Lunch Debate on “The future of dementia research in Europe” https://alzheimereurope.newsweaver.com/Newsletter/1cjaa7qlk2r?lang=en?rss=true On 2 December 2025, Alzheimer Europe held a lunch debate at the European Parliament in Brussels (Belgium), exploring the future of dementia research in Europe. The event was attended by national Alzheimer associations, civil society representatives, industry partners and policymakers, including MEPs. Our hosts were Co-Chairs of the European Alzheimer’s Alliance, Tilly Metz MEP (Luxembourg) and Sirpa Pietikäinen MEP (Finland). 23 Dec 2025 12:00:00 CET dd0acffeda28594b2a1ba9e750e12bd2 Other Articles <img align="left" src="https://alzheimereurope.newsweaver.com/v3files/shard1/56305/ac/38a21e9f2e730462d4c27c.jpg" style="margin: 5px;" width="150" height="150" hspace="5" vspace="5" alt="European Parliament Brussels (square)">On 2 December 2025, Alzheimer Europe held a lunch debate at the European Parliament in Brussels (Belgium), exploring the future of dementia research in Europe. The event was attended by national Alzheimer associations, civil society representatives, industry partners and policymakers, including MEPs. Our hosts were Co-Chairs of the European Alzheimer’s Alliance, Tilly Metz MEP (Luxembourg) and Sirpa Pietikäinen MEP (Finland).  https://www.alzheimer-europe.org/news/alzheimer-europe-hosts-european-parliament-lunch-debate-future-dementia-research-europe 2 December: Photographer Alex Kornhuber wins Alzheimer Europe’s 2025 Anti-Stigma Award https://alzheimereurope.newsweaver.com/Newsletter/9ir4fjzgtav?lang=en?rss=true On 2 December 2025, at a special award ceremony in Brussels (Belgium), Photographer Alex Kornhuber was announced as the winner of the 2025 Anti-Stigma-Award, for his series of portraits “Keepsake Chronicles”. Huge congratulations to him, and to runners-up Desideria Care e.V. (Germany) for their open-air photo exhibition “Seeing Dementia in a New Light”, and Hungarian photographer Bálint Szajki for his deeply intimate photo essay, “In Sickness and in Health”. Congratulations, also, to all six entries that received “honourable “mentions”. 23 Dec 2025 12:00:00 CET e5cc5e47d71be4bcbc555078110637c5 Other Articles <img align="left" src="https://alzheimereurope.newsweaver.com/v3files/shard1/56305/ab/e592ab2113a34d942db558.jpg" style="margin: 5px;" width="150" height="136" hspace="5" vspace="5" alt="Three winners of 2025 Anti Stigma Award">On 2 December 2025, at a special award ceremony in Brussels (Belgium), Photographer Alex Kornhuber was announced as the winner of the 2025 Anti-Stigma-Award, for his series of portraits “Keepsake Chronicles”. Huge congratulations to him, and to runners-up Desideria Care e.V. (Germany) for their open-air photo exhibition “Seeing Dementia in a New Light”, and Hungarian photographer Bálint Szajki for his deeply intimate photo essay, “In Sickness and in Health”. Congratulations, also, to all six entries that received “honourable “mentions”.  https://www.alzheimer-europe.org/news/photographer-alex-kornhuber-wins-alzheimer-europes-2025-anti-stigma-award 4 December: Highlights from the Clinical Trials on Alzheimer's Disease conference 2025 https://alzheimereurope.newsweaver.com/Newsletter/sqlthngnnqz?lang=en?rss=true The Clinical Trials on Alzheimer’s Disease (CTAD) conference 2025 took place in San Diego (USA), from 1 to 4 December. We have selected a few research highlights from the event. Check them out! 23 Dec 2025 12:00:00 CET decc16138ea9a81e00bf2175814d9c82 Other Articles <img align="left" src="https://alzheimereurope.newsweaver.com/v3files/shard1/56305/bd/18091ad3f7b5d793b1fafc.jpg" style="margin: 5px;" width="150" height="150" hspace="5" vspace="5" alt="">The Clinical Trials on Alzheimer’s Disease (CTAD) conference 2025 took place in San Diego (USA), from 1 to 4 December. We have selected a few research highlights from the event. Check them out! https://www.alzheimer-europe.org/news/highlights-clinical-trials-alzheimers-disease-conference-2025 9 December: Alzheimer Europe report highlights initiatives supporting people with dementia to use transport and access recreational activities https://alzheimereurope.newsweaver.com/Newsletter/1n0trukix8d?lang=en?rss=true On 9 December, Alzheimer Europe launched the Dementia in Europe Yearbook 2025, which highlights programmes and resources relating to transport and access to cultural life, recreation, leisure and sport. These topics are vital components in the lives of people with dementia and their carers, which help them to stay actively engaged in the communities in which they live. 23 Dec 2025 12:00:00 CET 3e77cce8f42f23ee6ab74817133501f7 Other Articles <img align="left" src="https://alzheimereurope.newsweaver.com/v3files/shard1/56305/3c/e698c2f15b844ef8fb7a06.png" style="margin: 5px;" width="150" height="155" hspace="5" vspace="5" alt="Dementia in Europe Yearbook 2025 cover">On 9 December, Alzheimer Europe launched the Dementia in Europe Yearbook 2025, which highlights programmes and resources relating to transport and access to cultural life, recreation, leisure and sport. These topics are vital components in the lives of people with dementia and their carers, which help them to stay actively engaged in the communities in which they live.  https://www.alzheimer-europe.org/news/alzheimer-europe-report-highlights-initiatives-supporting-people-dementia-use-transport-and 12 December: European Medicines Agency issues negative opinion on blarcamesine for the treatment of early Alzheimer’s disease https://alzheimereurope.newsweaver.com/Newsletter/49cc7vxlpcq?lang=en?rss=true The Committee for Medicinal Products for Human use (CHMP) of the European Medicines Agency has issued a negative opinion on the marketing authorisation application for blarcamesine for the treatment of early Alzheimer’s disease. We hope that the re-examination request lodged by Anavex will provide additional evidence for the CHMP to reconsider its position. 23 Dec 2025 12:00:00 CET b87f052ab7f38a58e3d1077f671d4621 Other Articles <img align="left" src="https://alzheimereurope.newsweaver.com/v3files/shard1/56305/fd/1034d33581a3b3e4bc7559.jpg" style="margin: 5px;" width="150" height="150" hspace="5" vspace="5" alt="">The Committee for Medicinal Products for Human use (CHMP) of the European Medicines Agency has issued a negative opinion on the marketing authorisation application for blarcamesine for the treatment of early Alzheimer’s disease. We hope that the re-examination request lodged by Anavex will provide additional evidence for the CHMP to reconsider its position. https://www.alzheimer-europe.org/news/european-medicines-agency-issues-negative-opinion-blarcamesine 17 December: We are hiring! Check out our two open positions for a Project Administrator and an Administrative and Conference Assistant https://alzheimereurope.newsweaver.com/Newsletter/12tn46oxr29?lang=en?rss=true Two full-time, permanent positions have opened up at Alzheimer Europe, for a Project Administrator and an Administrative and Conference Assistant. Please see our job advert for more details about how and when to apply. We look forward to hearing from you! 23 Dec 2025 12:00:00 CET 4b40ad78a3ec9134cf5817110af0705a Other Articles <img align="left" src="https://alzheimereurope.newsweaver.com/v3files/shard1/56305/e0/84313bc7894e2976e78bbc.jpg" style="margin: 5px;" width="150" height="150" hspace="5" vspace="5" alt="">Two full-time, permanent positions have opened up at Alzheimer Europe, for a Project Administrator and an Administrative and Conference Assistant. Please see our job advert for more details about how and when to apply. We look forward to hearing from you! https://www.alzheimer-europe.org/news/we-are-hiring-check-out-our-two-open-positions-project-administrator-and-administrative-and